Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration

NCT07367282 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Macular Degeneration

Interventions

DRUG: Faricimab Injection [Vabysmo]

Sponsor

Junyeop Lee